Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00987389Phase 3Completed
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
Granulomatosis With Polyangiitis (Wegener's) (GPA)Microscopic Polyangiitis (MPA)
PrincipalinvestigatorStart date: 2010-05-01

Research Network

Collaboration Network

7 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Cambridge University Hospitals NHS Foundation Trust

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Peter Merkel, MD, MPH

University of Pennsylvania

Related
4 trials

Shared therapeutic areas:

Granulomatosis With Polyangiitis (Wegener's) (GPA)Microscopic Polyangiitis (MPA)

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)+2 more
Collaborated on 1 trial
Similarity Score24%

Michael Walsh, MD

McMaster University

Related
1 trials

Shared therapeutic areas:

Granulomatosis With Polyangiitis (Wegener's) (GPA)Microscopic Polyangiitis (MPA)

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation TrustNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)+2 more
Collaborated on 1 trial
Similarity Score24%

Peter A Merkel, MD, MPH

University of Pennsylvania

Related
10 trials

Shared therapeutic areas:

Microscopic Polyangiitis (MPA)Granulomatosis With Polyangiitis (Wegener's) (GPA)

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)University of Pennsylvania
Similarity Score20%

Michael Walsh, MD

Cambridge University Hospitals NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Lupus Nephritis

Worked with same sponsors:

Cambridge University Hospitals NHS Foundation Trust
Collaborated on 1 trial
Similarity Score14%

David Wofsy, M.D.

University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center

Related
2 trials

Shared therapeutic areas:

Lupus Nephritis
Similarity Score10%

Yao zhong Kong, MD

Department of Nephrology, 1st People's Hospital of Foshan

Related
1 trials

Shared therapeutic areas:

Lupus Nephritis
Similarity Score10%

xiangmei chen

Chinese PLA General Hospital

Related
6 trials

Shared therapeutic areas:

Lupus Nephritis
Similarity Score10%

Jin li Zhang, MD

Department of nephrology, People's Hospital of Yunnan Province

Related
2 trials

Shared therapeutic areas:

Lupus Nephritis
Similarity Score10%

Xiaolei Ma, Doctor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Related
1 trials

Shared therapeutic areas:

Lupus Nephritis
Similarity Score10%

Jun zhou Fu, MD

Department of Nephrology,1st People's Hospital of Guangzhou

Related
1 trials

Shared therapeutic areas:

Lupus Nephritis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00987389Phase 3PrincipalInvestigator

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis

Granulomatosis With Polyangiitis (Wegener's) (GPA)Microscopic Polyangiitis (MPA)
Completed
NCT00539799Phase 3PrincipalInvestigator

Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis

Lupus Nephritis
Withdrawn

All 2 trials loaded